EvercoreNYSE: EVR

WATERTOWN, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions, today announced that Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf, and Randi Isaacs, M.D., Chief Medical Officer of Werewolf, will participate in a fireside chat at 12:55 pm ET on Thursday, December 5, 2024, at the 7th Annual Evercore ISI HealthCONx Healthcare Conference, taking place December 3-5 in Miami, Florida.

FRANKLIN LAKES, N.J. , Nov. 19, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024, at 10:50 am Eastern Time.

SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will participate in the Evercore 7th Annual HealthCONx Conference.

Mark Mahaney, Evercore ISI Head of Internet Research, joins 'Fast Money' to talk possible deregulation of self-driving under a Trump administration.

The stock-market rally still has room to run, as Donald Trump's stunning comeback for the White House and a potential Republican sweep in Congress may propel the S&P 500 to 6,600 by mid-2025, according to Evercore ISI Research.

Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell' to discuss Amazon ahead of earnings.

A solid segmental performance leads to an increase in EVR's revenue base, positively influencing its Q3 earnings. Yet, a rising expense base remains a concern.

Evercore Inc. (NYSE:EVR ) Q3 2024 Earnings Conference Call October 23, 2024 8:00 AM ET Company Participants Katy Haber - Managing Director, Investor Relations & ESG John Weinberg - Chairman & Chief Executive Officer Tim LaLonde - Chief Financial Officer Conference Call Participants Brendan O'Brien - Wolfe Research Ryan Kenny - Morgan Stanley James Yaro - Goldman Sachs Jim Mitchell - Seaport Global Devin Ryan - Citizens JMP Aidan Hall - KBW Mike Brown - Wells Fargo Operator Good morning and welcome to the Evercore Third Quarter 2024 Earnings Conference Call. Today's call is scheduled to last about one hour, including remarks by Evercore management and the question-and-answer session.

The headline numbers for Evercore (EVR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.